INTERCEPT PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2011 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $1.86M.
  • Intercept Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $4.17M.
  • Intercept Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$107M, a 197% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$35.9M, a 17.7% increase from 2020.
  • Intercept Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was -$43.7M, a 35.4% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $4.17M $1.86M +$95.8M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$91.6M $1.29M +$8.25M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$99.9M -$249K +$6.76M +96.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-04-27
Q4 2022 -$107M $1.27M +$16.9M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-02
Q3 2022 -$124M -$93.9M -$96.6M -3677% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$27M -$6.96M +$4.91M +41.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$31.9M -$7.01M +$4.07M +36.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 -$35.9M -$15.6M -$4.05M -35% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$31.9M $2.63M +$13.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$45.8M -$11.9M -$617K -5.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$45.2M -$11.1M -$1.54M -16.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$43.7M -$11.6M -$2.71M -30.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 -$41M -$11.3M -$2.01M -21.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$39M -$11.3M -$3.49M -45% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$35.5M -$9.54M -$3.21M -50.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$32.3M -$8.87M -$2.83M -47% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-02
Q3 2019 -$29.4M -$9.3M -$3.13M -50.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$26.3M -$7.76M -$2.35M -43.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$23.9M -$6.33M -$191K -3.11% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$23.8M -$6.03M +$269K +4.27% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$24M -$6.17M +$262K +4.08% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$24.3M -$5.42M +$639K +10.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$24.9M -$6.13M -$167K -2.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$24.8M -$6.3M -$268K -4.44% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$24.5M -$6.43M -$651K -11.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$23.8M -$6.06M -$6.85M -861% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$17M -$5.97M -$6.69M -922% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$10.3M -$6.04M -$6.67M -1049% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$3.62M -$5.78M -$6.67M -750% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $3.05M $796K -$134K -14.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $3.18M $726K +$454K +167% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $2.73M $636K +$329K +107% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $2.4M $889K +$661K +290% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.74M $930K -$55M -98.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $56.7M $272K +$227M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$170M $307K -$1.23M -80% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$169M $228K +$20.9M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$190M $55.9M +$61.8M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$251M -$226M -$223M -6589% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$28.3M $1.54M +$25.7M Oct 1, 2013 Dec 31, 2013 10-K 2014-03-14
Q3 2013 -$54M -$20.6M -$19.2M -1373% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$34.8M -$5.86M -$5.98M -5101% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$28.8M -$3.39M -$4.07M -598% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$24.7M -$24.1M -$24.9M -3139% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $191K -$1.4M -$1.59M -860% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $1.78M $117K +$25K +27.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $1.75M $680K +$658K +2940% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $1.09M $794K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 $184K Jul 1, 2011 Sep 30, 2011 10-K 2013-04-01
Q2 2011 $92.1K Apr 1, 2011 Jun 30, 2011 10-K 2013-04-01
Q1 2011 $22.4K Jan 1, 2011 Mar 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.